Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5094) 5094
Book Review (636) 636
Publication (171) 171
Book Chapter (49) 49
Conference Proceeding (15) 15
Magazine Article (12) 12
Web Resource (6) 6
Dissertation (3) 3
Book / eBook (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3753) 3753
male (3732) 3732
index medicus (3573) 3573
seminoma (2534) 2534
adult (2035) 2035
testicular neoplasms - pathology (1682) 1682
oncology (1323) 1323
seminoma - pathology (1262) 1262
middle aged (1172) 1172
cancer (1019) 1019
testis (932) 932
testicular cancer (861) 861
chemotherapy (796) 796
germ-cell tumors (736) 736
tumors (716) 716
urology & nephrology (688) 688
adolescent (652) 652
testicular neoplasms - surgery (639) 639
orchiectomy (620) 620
neoplasm staging (617) 617
testicular neoplasms - therapy (580) 580
female (573) 573
radiotherapy (561) 561
pathology (552) 552
seminoma - surgery (532) 532
testicular neoplasms - drug therapy (510) 510
aged (498) 498
testicular neoplasms - diagnosis (491) 491
prognosis (471) 471
testicular neoplasms (465) 465
seminoma - diagnosis (454) 454
seminoma - drug therapy (454) 454
seminoma - therapy (441) 441
neoplasms, germ cell and embryonal - pathology (419) 419
combined modality therapy (403) 403
immunohistochemistry (401) 401
testicular neoplasms - radiotherapy (400) 400
treatment outcome (395) 395
retrospective studies (391) 391
testicular neoplasms - genetics (384) 384
antineoplastic combined chemotherapy protocols - therapeutic use (363) 363
risk factors (353) 353
seminoma - radiotherapy (347) 347
diagnosis (337) 337
follow-up studies (336) 336
abridged index medicus (334) 334
surveillance (334) 334
testicular neoplasms - metabolism (305) 305
germ cell tumors (304) 304
young adult (297) 297
seminoma - genetics (296) 296
seminoma - metabolism (296) 296
management (286) 286
surgery (280) 280
testicular neoplasms - complications (276) 276
testicular seminoma (274) 274
diagnosis, differential (273) 273
seminoma - complications (270) 270
seminoma - secondary (269) 269
expression (267) 267
testicular neoplasms - epidemiology (253) 253
animals (249) 249
risk (248) 248
germ cell tumor (247) 247
neoplasms (247) 247
neoplasms, germ cell and embryonal (240) 240
testicular neoplasms - mortality (235) 235
tomography, x-ray computed (219) 219
carcinoma (218) 218
cisplatin (218) 218
teratoma (217) 217
care and treatment (215) 215
dysgerminoma (215) 215
medicine & public health (213) 213
radiology, nuclear medicine & medical imaging (212) 212
ovarian neoplasms (208) 208
metastasis (207) 207
old medline (203) 203
lymphatic metastasis (201) 201
antineoplastic agents - therapeutic use (199) 199
testicular neoplasms - diagnostic imaging (199) 199
germinoma - pathology (198) 198
seminoma - diagnostic imaging (197) 197
carboplatin (196) 196
testis - pathology (196) 196
spermatocytic seminoma (192) 192
child (191) 191
cisplatin - administration & dosage (191) 191
testes (181) 181
randomized-trial (178) 178
time factors (178) 178
seminoma - epidemiology (177) 177
seminoma - mortality (174) 174
urology (174) 174
incidence (173) 173
survival rate (172) 172
research (171) 171
neoplasms, germ cell and embryonal - therapy (169) 169
testis cancer (169) 169
chemotherapy, adjuvant (163) 163
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4261) 4261
French (249) 249
German (219) 219
Japanese (144) 144
Spanish (105) 105
Italian (46) 46
Chinese (37) 37
Russian (27) 27
Dutch (12) 12
Portuguese (12) 12
Polish (11) 11
Danish (8) 8
Hungarian (8) 8
Czech (7) 7
Turkish (6) 6
Korean (3) 3
Croatian (2) 2
Icelandic (2) 2
Norwegian (2) 2
Persian (2) 2
Serbian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)
by R. Timothy D. Oliver and Graham M. Mead and Gordon J.S. Rustin and Johnathan K. Joffe and Nina Aass and Robert Coleman and Rhian Gabe and Philip Pollock and Sally P. Stenning
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 957 - 962
Purpose Initial results of a randomized trial comparing carboplatin with radiotherapy (RT) as adjuvant treatment for stage I seminoma found carboplatin had a... 
SINGLE-AGENT CARBOPLATIN | DIAGNOSIS | MANAGEMENT | ONCOLOGY | TESTICULAR SEMINOMA | SURVEILLANCE | FOLLICLE-STIMULATING-HORMONE | ADJUVANT TREATMENT | POOLED ANALYSIS | GERM-CELL-CANCER | CHEMOTHERAPY | Testicular Neoplasms - mortality | Prospective Studies | Seminoma - therapy | Humans | Male | Antineoplastic Agents - therapeutic use | Testicular Neoplasms - pathology | Carboplatin - adverse effects | Carboplatin - therapeutic use | Time Factors | Antineoplastic Agents - adverse effects | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Testicular Neoplasms - therapy | Risk Assessment | Seminoma - drug therapy | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Radiation Dosage | Orchiectomy | Disease-Free Survival | Seminoma - mortality | Testicular Neoplasms - drug therapy | Neoplasm Staging | Seminoma - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
by Aparicio, J and Aparicio, J and Maroto, P and Maroto, P and García del Muro, X and García del Muro, X and Sánchez-Muñoz, A and Sánchez-Muñoz, A and Gumà, J and Gumà, J and Margelí, M and Margelí, M and Sáenz, A and Sáenz, A and Sagastibelza, N and Sagastibelza, N and Castellano, D and Castellano, D and Arranz, J.A and Arranz, J.A and Hervás, D and Hervás, D and Bastús, R and Bastús, R and Fernández-Aramburo, A and Fernández-Aramburo, A and Sastre, J and Sastre, J and Terrasa, J and Terrasa, J and López-Brea, M and López-Brea, M and Dorca, J and Dorca, J and Almenar, D and Almenar, D and Carles, J and Carles, J and Hernández, A and Hernández, A and Germà, J.R and Germà, J.R
Annals of Oncology, ISSN 0923-7534, 11/2014, Volume 25, Issue 11, pp. 2173 - 2178
A new nomogram was developed to predict disease-free survival in stage I seminoma. Rete testis invasion and tumor size resulted independent predictors of... 
stage I | adjuvant carboplatin | prognostic factors | seminoma | surveillance | DIAGNOSIS | CARBOPLATIN | MANAGEMENT | TESTICULAR SEMINOMA | GUIDELINES | CHEMOTHERAPY | ONCOLOGY | OUTCOMES | Prognosis | Seminoma - drug therapy | Humans | Risk Factors | Neoplasm Recurrence, Local - drug therapy | Male | Combined Modality Therapy | Neoplasm Recurrence, Local - surgery | Orchiectomy | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Adolescent | Nomograms | Seminoma - radiotherapy | Adult | Chemotherapy, Adjuvant | Neoplasm Staging | Seminoma - surgery | Seminoma - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Bloating due to massive seminoma in an undescended testis
by Zhu, Julia L and Roberts, Matthew J and Navaratnam, Anojan and Chung, Eric and Wood, Simon T
ANZ Journal of Surgery, ISSN 1445-1433, 04/2019, Volume 89, Issue 4, pp. E160 - E161
SURGERY | Seminoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance
by Chung, Peter and Daugaard, Gedske and Tyldesley, Scott and Atenafu, Eshetu G and Panzarella, Tony and Kollmannsberger, Christian and Warde, Padraig
Cancer Medicine, ISSN 2045-7634, 01/2015, Volume 4, Issue 1, pp. 155 - 160
A prognostic model for relapse risk in stage I seminoma managed by surveillance after orchiectomy has been developed but has not been independently validated.... 
Prognostic model | stage I seminoma | surveillance | Surveillance | Stage i seminoma | GERM-CELL CANCER | DIAGNOSIS | LONG-TERM SURVIVORS | MANAGEMENT | ONCOLOGY | TESTICULAR SEMINOMA | EUROPEAN CONSENSUS | Testicular Neoplasms - mortality | Prognosis | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Risk | Testicular Neoplasms - epidemiology | Tumor Burden | Testicular Neoplasms - pathology | Young Adult | Seminoma - epidemiology | Seminoma - mortality | Canada - epidemiology | Public Health Surveillance | Adolescent | Aged, 80 and over | Adult | Aged | Neoplasm Staging | Seminoma - surgery | Seminoma - pathology | Relapse | Diseases | Index Medicus | Cancer Prevention
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
by Oliver, RTD and Mason, MD and Mead, GM and von der Maase, H and Rustin, GJS and Joffe, JK and de Wit, R and Aass, N and Graham, JD and Coleman, R and Kirk, SJ and Stenning, SP and EORTC30982 Collaborators and MRC TE10 Collaborators and MRC TE19 collaborators and the EORTC 30982 collaborators
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9482, pp. 293 - 300
Adjuvant radiotherapy is effective treatment for stage I seminoma, but is associated with a risk of late non-germ-cell cancer and cardiovascular events. After... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | THERAPY | TESTIS | TESTICULAR SEMINOMA | GERM-CELL TUMORS | SURVEILLANCE | POOLED ANALYSIS | AGENT CARBOPLATIN | CANCER | CHEMOTHERAPY | Testicular Neoplasms - mortality | Seminoma - drug therapy | Humans | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Male | Survival Rate | Lymphatic Metastasis | Antineoplastic Agents - administration & dosage | Orchiectomy | Testicular Neoplasms - surgery | Seminoma - mortality | Testicular Neoplasms - drug therapy | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Adult | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Seminoma - surgery | Analysis | Carboplatin | Dosage and administration | Diagnosis | Radiotherapy | Drug therapy | Health aspects | Testicular cancer | Comparative studies | Therapy | Drug dosages | Medical treatment | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
by Tandstad, Torgrim and Ståhl, O and Dahl, O and Haugnes, H.S and Håkansson, U and Karlsdottir, A and Kjellman, A and Langberg, C.W and Laurell, A and Oldenburg, J and Solberg, A and Söderström, K and Stierner, U and Cavallin-Ståhl, E and Wahlqvist, R and Wall, N and Cohn-Cedermark, G and SWENOTECA and Region Östergötland and Medicinska fakulteten and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Onkologiska kliniken US and Avdelningen för kliniska vetenskaper and Centrum för kirurgi, ortopedi och cancervård
Annals of Oncology, ISSN 0923-7534, 07/2016, Volume 27, Issue 7, pp. 1299 - 1304
A total of 1118 patients with clinical stage I seminoma one course of adjuvant carboplatin or managed by surveillance were included. Stromal invasion of rete... 
Seminoma | Surveillance | Risk-adapted | Testicular cancer | Prognostic factors | Adjuvant carboplatin | testicular cancer | risk-adapted | RELAPSE | PROGNOSTIC-FACTORS | ONCOLOGY | PATTERNS | adjuvant carboplatin | prognostic factors | seminoma | surveillance | GERM-CELL-CANCER | Seminoma - drug therapy | Humans | Middle Aged | Risk Factors | Carboplatin - administration & dosage | Neoplasm Recurrence, Local - drug therapy | Male | Treatment Outcome | Combined Modality Therapy - adverse effects | Sweden - epidemiology | Carboplatin - adverse effects | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Seminoma - epidemiology | Chemotherapy, Adjuvant - adverse effects | Norway - epidemiology | Adult | Aged | Neoplasm Recurrence, Local - epidemiology | Neoplasm Staging | Seminoma - pathology | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | testicular cancer; seminoma; surveillance; adjuvant carboplatin; risk-adapted; prognostic factors | Surgery | Klinisk medicin | Kirurgi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy
by Leung, Eric and Warde, Padraig and Jewett, Michael and Panzarella, Tony and O'Malley, Martin and Sweet, Joan and Moore, Malcolm and Sturgeon, Jeremy and Gospodarowicz, Mary and Chung, Peter
BJU International, ISSN 1464-4096, 12/2013, Volume 112, Issue 8, pp. 1088 - 1095
Objective To examine the management and outcomes of patients with stage I seminoma and to relate these to overall treatment burden. Patients and Methods A... 
treatment | stage 1 | seminoma | surveillance | radiation | burden | DIAGNOSIS | LONG-TERM SURVIVORS | GERM-CELL TUMORS | RANDOMIZED-TRIAL | RISK | IIA/B TESTICULAR SEMINOMA | CANCER | ORCHIECTOMY | DISEASE | UROLOGY & NEPHROLOGY | RADIOTHERAPY | Neoplasm Recurrence, Local - radiotherapy | Testicular Neoplasms - mortality | Seminoma - drug therapy | Humans | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Male | Treatment Outcome | Tumor Burden | Neoplasm Recurrence, Local - mortality | Orchiectomy | Testicular Neoplasms - surgery | Seminoma - mortality | Testicular Neoplasms - drug therapy | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Watchful Waiting | Chemotherapy, Adjuvant | Neoplasm Staging | Radiotherapy, Adjuvant | Seminoma - surgery | Salvage Therapy - methods | Chemotherapy | Comparative analysis | Radiotherapy | Nuclear radiation | Cancer | Surgery | Radiation therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Surveillance versus adjuvant radiotherapy for patients with high‐risk stage I seminoma
by Mortensen, Mette S and Bandak, Mikkel and Kier, Maria G. G and Lauritsen, Jakob and Agerbæk, Mads and Holm, Niels V and von der Maase, Hans and Daugaard, Gedske
Cancer, ISSN 0008-543X, 04/2017, Volume 123, Issue 7, pp. 1212 - 1218
The treatment of patients with high‐risk, stage I seminoma has shifted from adjuvant radiotherapy to surveillance in many centers. Although the risk of disease... 
testicular cancer | treatment burden | adjuvant radiotherapy | seminoma | surveillance | GERM-CELL CANCER | REGISTER | CARBOPLATIN | PATTERNS | SWENOTECA | RELAPSE | ONCOLOGY | TESTIS | EXPERIENCE | Follow-Up Studies | Humans | Risk Factors | Male | Treatment Outcome | Tumor Burden | Young Adult | Seminoma - epidemiology | Seminoma - mortality | Radiotherapy, Adjuvant - methods | Adolescent | Seminoma - radiotherapy | Denmark - epidemiology | Adult | Neoplasm Staging | Child | Population Surveillance | Seminoma - pathology | Treatment outcome | Care and treatment | Usage | Relapse | Germ cell tumors | Analysis | Radiotherapy | Risk factors | Diseases | Risk groups | Identification methods | Medical services | Health risks | Radiation therapy | Patients | Survival | Incidence | Seminoma | Surveillance | Risk assessment | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Carboplatin in clinical stage I seminoma: Too much and too little at the same time
by Bosl, George J and Patil, Sujata
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 949 - 952
GERM-CELL CANCER | SINGLE-AGENT CARBOPLATIN | COUNCIL RANDOMIZED-TRIAL | CISPLATIN | ONCOLOGY | EUROPEAN ORGANIZATION | TESTICULAR SEMINOMA | ADJUVANT TREATMENT | POOLED ANALYSIS | METASTATIC SEMINOMA | CHEMOTHERAPY | Testicular Neoplasms - mortality | Seminoma - therapy | Humans | Male | Antineoplastic Agents - therapeutic use | Testicular Neoplasms - pathology | Carboplatin - adverse effects | Multicenter Studies as Topic | Carboplatin - therapeutic use | Time Factors | Antineoplastic Agents - adverse effects | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Testicular Neoplasms - therapy | Risk Assessment | Seminoma - drug therapy | Risk Factors | Neoplasm Recurrence, Local | Treatment Outcome | Radiation Dosage | Orchiectomy | Randomized Controlled Trials as Topic | Disease-Free Survival | Seminoma - mortality | Testicular Neoplasms - drug therapy | Neoplasm Staging | Research Design | Seminoma - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program
by Mortensen, Mette Saksø|Lauritsen, Jakob|Gundgaard, Maria Gry|Agerbæk, Mads|Holm, Niels Vilstrup|Christensen, Ib Jarle|von der Maase, Hans|Daugaard, Gedske
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 6, pp. 1172 - 1178
Abstract Background Increasing concerns about late effects after adjuvant treatment for stage I seminoma have made surveillance an attractive alternative.... 
Urology | Surveillance | Germ cell cancer | Stage I seminoma | Germ cell cancer Stage I seminoma Surveillance | DIAGNOSIS | REGISTER | MANAGEMENT | PROGNOSTIC-FACTORS | GUIDELINES | TESTICULAR CANCER | RELAPSE | ORCHIECTOMY | TESTIS | UROLOGY & NEPHROLOGY | Follow-Up Studies | Seminoma - therapy | Blood Vessels - pathology | Humans | Middle Aged | Male | Testicular Neoplasms - pathology | Young Adult | Aged, 80 and over | Adult | Retrospective Studies | Testicular Neoplasms - therapy | Neoplasm Invasiveness | Neoplasm Recurrence, Local - therapy | Survival Rate | Tumor Burden | Orchiectomy | Disease-Free Survival | Epididymis - pathology | Adolescent | Denmark | Watchful Waiting | Aged | Neoplasm Staging | Seminoma - pathology | Medicine, Experimental | Medical research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results
by De Felice, Francesca and Musio, Daniela and Gravina, Giovanni Luca and Marampon, Francesco and Tombolini, Vincenzo
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 48, pp. 80077 - 80082
Aim: To report long term oncologic outcomes after adjuvant radiotherapy (RT) for stage I seminoma. Method: We reviewed the complete data set for all patients... 
Chemotherapy | Surveillance | Radiotherapy | Stage I seminoma | Orchiectomy | RELAPSE | PROGNOSTIC-FACTORS | orchiectomy | radiotherapy | RISK | stage I seminoma | surveillance | chemotherapy | CELL BIOLOGY | Testicular Neoplasms - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Testicular Neoplasms - pathology | Testicular Neoplasms - surgery | Young Adult | Neoplasm Metastasis | Seminoma - mortality | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Survival Analysis | Adult | Aged | Retrospective Studies | Neoplasm Staging | Radiotherapy, Adjuvant | Seminoma - surgery | Seminoma - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Spermatocytic seminoma with rhabdomyosarcomatous differentiation: A case report with a review of the literature
by Menon, Santosh and Karpate, Arti and Desai, Sangeeta
01/2010
Spermatocytic seminoma is an uncommon testicular germ cell tumor associated with a favorable outcome. Sarcomatous transformation in a spermatocytic seminoma is... 
Spermatocytic seminoma | rhabdomyosarcomatous differentiation
Web Resource
Details down arrow
13. Full Text Adverse Prognostic Factors for Testicular Cancer–Specific Survival: A Population-Based Study of 27,948 Patients
by Sophie D. Fosså and Milada Cvancarova and Linlin Chen and Annie L. Allan and Jan Oldenburg and Derick R. Peterson and Lois B. Travis
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 963 - 970
Purpose The prognostic significance of age at testicular cancer (TC) diagnosis, socioeconomic status (SES), race, and marital status on TC-specific mortality... 
MORTALITY | ONCOLOGY | STAGE | GERM-CELL TUMORS | MARRIAGE | BLEOMYCIN | MALIGNANCIES | TOXICITY | CARCINOMA | SEMINOMA | CHEMOTHERAPY | Lymph Node Excision | United States - epidemiology | Testicular Neoplasms - mortality | Age Factors | Seminoma - therapy | Humans | Middle Aged | Testicular Neoplasms - ethnology | Male | Neoplasms, Germ Cell and Embryonal - diagnosis | Socioeconomic Factors | Seminoma - diagnosis | Young Adult | Time Factors | Seminoma - ethnology | Aged, 80 and over | Adult | Neoplasms, Germ Cell and Embryonal - mortality | Testicular Neoplasms - diagnosis | Testicular Neoplasms - therapy | SEER Program | Risk Assessment | Neoplasm Invasiveness | Neoplasms, Germ Cell and Embryonal - ethnology | Risk Factors | Proportional Hazards Models | Treatment Outcome | Marital Status | Seminoma - mortality | Adolescent | Survival Analysis | Aged | Neoplasms, Germ Cell and Embryonal - therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Risk factors for loss to follow-up during active surveillance of patients with stage I seminoma
by Endo, Tsuyoshi and Kawai, Koji and Kamba, Tomomi and Inai, Hiromu and Uchida, Kazunori and Miyazaki, Jun and Kamoto, Toshiyuki and Ogawa, Osamu and Nishiyama, Hiroyuki
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 2014, Volume 44, Issue 4, pp. 355 - 359
To elucidate the patterns and risk factors for loss to follow-up during active surveillance for Stage I seminoma. A total of 425 cases with Stage I seminoma... 
Seminoma | Active surveillance | Loss to follow-up | Testicular cancer | Younger age | MANAGEMENT | QUALITY | TESTICULAR SEMINOMA | GERM-CELL TUMORS | CANCER | younger age | CARE | testicular cancer | ONCOLOGY | TESTIS | loss to follow-up | seminoma | active surveillance | Japan - epidemiology | Testicular Neoplasms - mortality | Age Factors | Follow-Up Studies | Seminoma - therapy | Patient Dropouts - psychology | Humans | Middle Aged | Male | Testicular Neoplasms - pathology | Testicular Neoplasms - surgery | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Adult | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Patient Dropouts - statistics & numerical data | Testicular Neoplasms - therapy | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Orchiectomy | Disease-Free Survival | Seminoma - mortality | Aged | Neoplasm Staging | Asian Continental Ancestry Group - statistics & numerical data | Population Surveillance | Research Design | Seminoma - surgery | Seminoma - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Outcomes in stage I testicular seminoma: A population‐based study of 9193 patients
by Beard, Clair J and Travis, Lois B and Chen, Ming‐Hui and Arvold, Nils D and Nguyen, Paul L and Martin, Neil E and Kuban, Deborah A and Ng, Andrea K and Hoffman, Karen E
Cancer, ISSN 0008-543X, 08/2013, Volume 119, Issue 15, pp. 2771 - 2777
Despite high cure rates following treatment for stage I testicular seminoma, survivors experience increased all‐cause mortality and mortality from second... 
testicular cancer | cardiovascular disease | suicide | radiotherapy | all‐cause mortality | seminoma | second malignant neoplasm | survivor | all-cause mortality | MORTALITY | LONG-TERM SURVIVORS | GERM-CELL TUMORS | 2ND CANCERS | CHEMOTHERAPY | CANCER-PATIENTS | ONCOLOGY | CARDIOVASCULAR-DISEASE | SURVEILLANCE | LIFE | United States - epidemiology | Testicular Neoplasms - mortality | Humans | Middle Aged | Male | Neoplasms, Second Primary - mortality | Neoplasms, Second Primary - radiotherapy | Testicular Neoplasms - pathology | Young Adult | Testicular Neoplasms - radiotherapy | Seminoma - radiotherapy | Cardiovascular Diseases - epidemiology | Adult | SEER Program | Seminoma - drug therapy | Risk Factors | Proportional Hazards Models | Treatment Outcome | Seminoma - mortality | Testicular Neoplasms - drug therapy | Adolescent | Aged | Neoplasm Staging | Neoplasms, Second Primary - drug therapy | Neoplasms, Second Primary - pathology | Seminoma - pathology | Usage | Demographic aspects | Patient outcomes | Diagnosis | Cardiovascular diseases | Radiotherapy | Testicular cancer | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text The Search for Biomarkers of Metastatic Seminoma
by Ruf, C.G.|Khalili-Harbi, N.|Sachs, S.|Isbarn, H.|Wagner, W.|Matthies, C.|Meineke, V.|Fisch, M.|Chun, F.K.|Abend, M
Journal of Urology, The, ISSN 0022-5347, 2013, Volume 190, Issue 3, pp. 1046 - 1051
Purpose We screened 90 potential parameters as biomarkers of metastatic seminoma to facilitate detection and eliminate unnecessary therapeutic or diagnostic... 
Urology | neoplasm metastasis | seminoma | tumor burden | testicular neoplasms | DIAGNOSIS | PROGNOSTIC-FACTORS | TESTICULAR SEMINOMA | CONSENSUS | STAGE-I SEMINOMA | CANCER | RELAPSE | ORCHIECTOMY | SURVEILLANCE | UROLOGY & NEPHROLOGY | UPDATE | Immunohistochemistry | Multivariate Analysis | Predictive Value of Tests | Seminoma - blood | Confidence Intervals | Follow-Up Studies | Seminoma - therapy | Humans | Middle Aged | Chorionic Gonadotropin, beta Subunit, Human - blood | Male | Testicular Neoplasms - pathology | Neoplasm Metastasis | Neoplasm Invasiveness - pathology | Adult | Retrospective Studies | Odds Ratio | alpha-Fetoproteins - metabolism | Testicular Neoplasms - therapy | Risk Assessment | Treatment Outcome | Tumor Burden | Biomarkers, Tumor - blood | L-Lactate Dehydrogenase - blood | Combined Modality Therapy - methods | Neoplasm Staging | Testicular Neoplasms - blood | Seminoma - secondary | Cohort Studies | Medical colleges | Pituitary hormones | Chorionic gonadotropin | Armed Forces | Glycoproteins | Metastasis | Biological markers | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights